Ashland (ASH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Dec, 2025Executive summary
Fiscal 2025 focused on disciplined execution, portfolio optimization, and sustainability integration, with resilient earnings, margin expansion, and strong free cash flow despite lower sales from divestitures and rationalizations.
Completed sale of Avoca business, delivered $30M in restructuring savings, and advanced a $60M manufacturing optimization program.
Repurchased $100M in stock; $520M remains authorized under the 2023 repurchase program.
Continued progress on Science Based Targets for emissions and maintained a strong safety record.
Looking ahead, priorities include investing in differentiated technologies, advancing sustainability, disciplined capital allocation, and fostering an inclusive culture.
Voting matters and shareholder proposals
Stockholders will vote to elect eight directors, ratify Ernst & Young LLP as independent auditor for fiscal 2026, and approve a non-binding advisory resolution on executive compensation.
Board recommends voting FOR all proposals.
Only stockholders of record as of November 21, 2025, are entitled to vote.
Board of directors and corporate governance
Board leadership combines Chair/CEO role with a Lead Independent Director for balance and oversight.
Four standing committees: Audit, Compensation, Sustainability and Productivity, and Governance & Nominating, all composed of independent directors.
Annual board and committee evaluations, director orientation, and continuing education are emphasized.
Board diversity: 2 females, 6 males; racial/ethnic diversity includes Hispanic/Latino, Asian/South Asian, and White/Caucasian; tenure ranges from 1 to 7+ years.
Majority of directors are independent; only the CEO/Chair is not.
Latest events from Ashland
- Sales down 5%, net loss improved to $12M, and Adjusted EBITDA guidance narrowed to $400–$420M.ASH
Q1 20263 Feb 2026 - Adjusted EBITDA rose 5% on flat sales, with Q4 margin gains expected amid muted demand.ASH
Q3 20242 Feb 2026 - All agenda items were approved, with no shareholder questions raised during the meeting.ASH
AGM 202620 Jan 2026 - Q4 adjusted EBITDA jumped 68% on margin recovery; FY2025 outlook cautious amid China risks.ASH
Q4 202416 Jan 2026 - Targeting robust growth and higher margins via innovation, globalization, and $90M in self-help.ASH
Status Update11 Jan 2026 - Sales fell 14% and net loss hit $165M, but guidance is reaffirmed amid ongoing headwinds.ASH
Q1 20259 Jan 2026 - Virtual Annual Meeting to vote on directors, auditor, and executive pay; online voting enabled.ASH
Proxy Filing9 Dec 2025 - Strategic growth, board diversity, and ESG progress highlight this year's proxy voting agenda.ASH
Proxy Filing1 Dec 2025 - Virtual annual meeting set for January 21, 2025, with key votes on directors and compensation.ASH
Proxy Filing1 Dec 2025